PRAX Q2 2021 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$6B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$36M

Net Income

-$36M

EPS (Diluted)

$-13.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$354M

Total Liabilities

$20M

Stockholders' Equity

$334M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$36M	-$12M	-215.3%
Net Income	-$36M	-$12M	-214.7%